Skip to main content

The NCI Community Hub (NCI Hub) will be offline for maintenance December 2-3, 2022 as we migrate URLs from to The current address will automatically redirect to the new URL. The NCI Hub will continue to function as usual after the migration. Please be sure to update any bookmarks or favorites to the new URL. close

eeDAP studies: Polling for T-con times and Pathology Informatics Update

First, I hope you are interested and ready for a T-con. Please visit this link to enter your times of availability


Next, if you do nothing else, please make sure I have at least correctly identified the lead of each team at . Of course, I hope everyone will also consider updating their “Team and Objectives” page. Check out those of the “Ready” teams.


Last, I have been on the phone with Ul Balis about the Pathology Informatics conference. He wants the WSI WG meeting at the conference again (Sunday afternoon 5/21/17). We also discussed two additional ways to participate in the main conference. He offered me a presentation slot to discuss this eeDAP studies project and he offered a special poster opportunity. The special poster would include a table and power to set up an eeDAP system in the exhibit hall. I am planning on having my assistant man the table to demo the eeDAP system and organize *data collection* throughout the conference.


I hope all of you can come to the Sunday meeting. I hope some of you are interested in providing an update of your work either during the Sunday meeting or on a poster. I am sticking my neck out big time because I believe in this project.


Please visit the link to enter your times you are available for a T-con as soon as possible. We have a lot to talk about. Also, I am archiving emails at


Brandon D. Gallas, PhD

Center For Devices and Radiological Health
Office of Science and Engineering Laboratories
U.S. Food and Drug Administration

Tel: 301-796-2531


Excellent customer service is important to us. Please take a moment to provide feedback regarding the customer service you have received:



Comments on this entry

There are no comments at this time.

Post a comment

You must log in to post comments.

Please keep comments relevant to this entry.

Line breaks and paragraphs are automatically converted. URLs (starting with http://) or email addresses will automatically be linked.